Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-09-13
1988-07-12
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549 75, 549 77, 549 78, 549 79, 549 80, A61K 3138, C07D33312
Patent
active
047570849
ABSTRACT:
Analogs of 2,5-Diaryl tetrahydrothiophenes which were substituted or unsubstituted on 3,4-positions were prepared.
These compounds are found to be leukotriene inhibitors and potent and specific PAF (Platelet Activating Factor) antagonists. They are therefore useful in the treatment of various diseases or disorders mediated by the leukotriene and/or PAF, for example, inflammation, cardiovascular disorder, asthma, lung edema, adult respiratory distress syndrome, pain, and aggregation of platelets.
REFERENCES:
patent: 2439345 (1948-04-01), Morris
patent: 3644399 (1969-05-01), Brown et al.
patent: 3655692 (1972-04-01), Shen
Parnes, Chem. Abst. 90: 87166p (1979).
Biftu et al., J. Chem. Soc. 1147 (1978).
Biftu et al., J. Chem. Soc. 2276 (1979).
Cheng Theresa Y.
Merck & Co. , Inc.
Siegel Alan
Sudol Michael C.
LandOfFree
2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664786